Codman & Shurtleff has announced it has received FDA clearance through a PMA supplement for its new programmable infusion system, according to a news release. The MEDSTREAM system is an implantable ...
The global neurological device company, Codman & Shurtleff, Inc. (Codman) has received the US Food and Drug Administration (FDA) approval through a PMA supplement for its Medstream Programmable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback